Back

Results - Announcements

Sales rise 99.65% to Rs 148.88 crore

Syncom Formulations (India) consolidated net profit rises 139.05% in the March 2025 quarter

20-May-2025, 07:45
Net profit of Syncom Formulations (India) rose 139.05% to Rs 17.69 crore in the quarter ended March 2025 as against Rs 7.40 crore during the previous quarter ended March 2024. Sales rose 99.65% to Rs 148.88 crore in the quarter ended March 2025 as against Rs 74.57 crore during the previous quarter ended March 2024.

For the full year,net profit rose 95.30% to Rs 49.43 crore in the year ended March 2025 as against Rs 25.31 crore during the previous year ended March 2024. Sales rose 76.55% to Rs 465.01 crore in the year ended March 2025 as against Rs 263.39 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	148.88	74.57	100	465.01	263.39	77
OPM %	11.92	12.63	-	11.64	11.25	-
PBDT	24.58	11.33	117	70.70	38.70	83
PBT	23.29	10.03	132	65.50	33.97	93
NP	17.69	7.40	139	49.43	25.31	95